Weight loss drug lorcaserin improves cardiometabolic health

Modest weight loss associated with the use of lorcaserin has been shown to improve cardiometabolic health in people who are overweight, obese or have a high cardiovascular risk. The findings with the serotonergic agonist are consistent with other evidence such as the DiRECT trial that weight loss can help with remission with type 2 diabetes. ...

Already a member?

Login to keep reading.

© 2021 the limbic